Jinshuibao belongs to the nourishing category and is not included in medical insurance. Only patients with nephrotic syndrome can be reimbursed appropriately. The medicine of this ingredient is an over-the-counter medicine for deficiency of internal medicine. This is a Chinese patent medicine. Drugs included in the basic medical insurance drug list are clinically necessary, safe and effective, reasonably priced, convenient to use, and the market can guarantee the supply of drugs. Several conditions must be met. Medical expenses that meet the basic medical insurance drug list shall be paid from the basic medical insurance fund in accordance with state regulations.
According to the drug list of basic medical insurance, industrial injury insurance and maternity insurance in Beijing [20 10] (referred to as drug list), Jinshuibao capsule is not a medical insurance reimbursement drug. However, Jinshuibao capsules are not expensive. If necessary, please consult and buy in a regular pharmacy. Its approval number is Z 10890003, and the manufacturer is Jiangxi Jimin Kexin Pharmaceutical Co., Ltd.
Jinshuibao capsule has the functions of tonifying lung and kidney, replenishing qi and essence, relieving cough, regulating immune function and improving microcirculation. Jinshuibao capsule is a traditional Chinese medicine preparation, which has a good therapeutic effect on patients with deficiency of both lung and kidney. Patients with lung qi deficiency and kidney essence deficiency may have a series of symptoms such as chronic fatigue, dyspnea, memory loss, poor sleep, soreness of waist and knees. After taking Jinshuibao capsule, it can play the role of tonifying lung and kidney, thus improving these symptoms. Jinshuibao capsule also has the function of tonifying lung and relieving cough, and can be used to treat chronic bronchitis. Jinshuibao capsule can regulate immune function, regulate hormone secretion and improve patients' immunity. Jinshuibao capsule can also improve microcirculation, reduce the occurrence of proteinuria and prevent further damage to renal function.
Legal basis:
People's Republic of China (PRC) social insurance law
Twenty-eighth medical expenses that meet the basic medical insurance drug list, diagnosis and treatment items, medical service facilities standards and emergency treatment and rescue shall be paid by the basic medical insurance fund in accordance with state regulations.
Twenty-ninth medical expenses of the insured shall be paid by the basic medical insurance fund, and shall be directly settled by the social insurance agency, medical institutions and pharmaceutical business units.
The administrative department of social insurance and the administrative department of health shall establish a settlement system for medical expenses in different places to facilitate the insured to enjoy the basic medical insurance benefits.